Effect of infarct artery patency on prognosis after acute myocardial infarction

Circulation

Volumn 92, Issue 5, 1995, Pages 1101-1109

  Lamas, Gervasio A ^a,b   Flaker, Greg C ^c   Mitchell, Gary ^d   Smith Jr , Sidney C ^e   Gersh, Bernard J ^f   Wun, Chuan Chuan ^g   Moyé, Lemuel ^g   Rouleau, Jean L ⁱ   Rutherford, John D ^h   Pfeffer, Marc A ^d   Braunwald, Eugene ^d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

Author keywords

arteries; captopril; myocardial infarction; receptors, adrenergic, beta; ventricles

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION;

EID: 0029166814     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.5.1101     Document Type: Article

References (54)

1. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988:2:349-360.
2. GISSI (Gruppo Italiano per lo Studio della Streptochinasi NeH'Infarto Miocardico). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-402.
3. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
5. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 1987;75:299-306.
6. Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J. 1988;116:1508-1513.
7. Force T, Kemper A, Leavitt M, Parisi AF. Acute reduction in functional infarct expansion with late coronary reperfusion: assessment with quantitative two-dimensional echocardiography. J Am Coll Cordial. 1988;11:192-200.
8. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983;309:1477-1482.
9. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded? Circulation. 1989;79:441-444.
10. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol. 1989;64:155-160.
11. Califf RM, Topol EJ, Gersh BJ. From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy. J Am Coll Cardiol. 1989;14:1382-1388.
12. Schroder R, Neuhaus K-L, Linderer T, Bruggemann T, Tebbe U, Wegscheider K. Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM Study). Am J Cardiol. 1989;64:878-884.
13. Fortin DF, Califf RM. Long-term survival from acute myocardial infarction: salutary effect of an open coronary vessel. Am J Med. 1990;88:9N-15N.
14. Gersh BJ. Benefits of the open artery: beyond myocardial salvage. J Myocard Ischemia. 1990;2:15-37.
15. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium: the open artery hypothesis. Circulation. 1993;88:2426-2436.
16. Lamas GA, Pfeffer MA, Braunwald E. Patency of the infarct-related coronary artery and ventricular geometry. Am J Cardiol. 1991;68:41D-51D.
17. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol. 1993;21:683-691.
18. Galvani M, Ottani F, Ferrini D, Sorbello F, Rusticali F. Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave acute myocardial infarction. Am J Cardiol. 1993;71:1-7.
19. Pfeffer MA, Braunwald E, Moye L, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S. Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
20. AJRE (The Acute Infarction Ramipril Efficacy) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-826.
21. Green KG, Chamberlain DA, Fulton RM, Hamer NAJ, Oliver MF, Pentecost BL. Reduction in mortality after myocardial infarction with long-term B-adrenoceptor blockade: multicenter international study: supplementary report. Br Med J. 1977;2:419-421.
22. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-807.
23. B-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, 1: mortality results. JAMA. 1981;247:1707-1714.
24. Glamann DB, Lange RA, Hillis LD. Beneficial effect of long-term beta blockade after myocardial infarction in patients without anterograde flow in the infarct artery. Am J Cardiol. 1991;68:150-154.
25. Moye LA, Pfeffer MA, Braunwald E. Rationale, design and baseline characteristics of the Survival and Ventricular Enlargement Trial. Am J Cardiol. 1991;68:70D-79D.
26. CASS Investigators. Chest x-ray and coronary arteriography. Circulation. 1981;63:58-68.
27. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret L, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation. 1987;76: 142-154.
28. Grossman W. Profiles in valvular heart disease. In: Grossman W, Baim DS, eds. Cardiac Catheterization, Angiography and Intervention. 4th ed. Philadelphia, Pa: Lea & Febiger; 1991:557-581.
29. Wynne J, Green L, Mann T, Levin D, Grossman W. Estimation of left ventricular volumes in man from biplane cincangiograms filmed in oblique projections. Am J Cardiol. 1978;41:726-732.
30. Lamas GA, Vaughan DE, Parisi AF, Pfeffer MA. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol. 1989;63:1167-1172.
31. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation. 1986;74: 293-305.
32. Cox DR. Regression models and life-tables. J R Stat Soc (B). 1972;34:187-220.
33. Hosmer DW, Lemeshow SL. Applied Logistic Regression. New York. NY: John Wiley & Sons; 1989.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
35. Lee ET. Statistical Methods for Survival Data Analysis. New York, NY: John Wiley & Sons; 1992.
36. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897-902.
37. Morgan CD, Roberts RS, Hag A, Baigrie RS, Daly PA, Gent M, Armstrong PW (for the TPA Study Group). Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group. J Am Coll Cardiol. 1991;17:1451-1457.
38. GUSTO Angiographie Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615-1622.
39. Braunwald E. The open-artery theory is alive and well-again. N Engl J Med. 1993;329:1650-1652.
40. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet. 1993;342:759-766.
41. Jeremy RW, Hackworthy RA, Bautovich G. Hutton BF, Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol. 1987;9:989-995.
42. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
43. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
44. Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA. Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Candiol. 1992;19:1136-1144.
45. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, Wall T, O'Brien M, Schwaiger M, Aguirre FV, Young S, Popma JJ, Sigmon KN, Lee KL, Ellis SG. and the Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation. 1992;85:2090-2099.
46. Gang ES, Lew AS, Hong M, Wang FZ, Siebert CA, Peter T. Decreased incidence of ventricular late potentials after successful thrombolylic therapy for acute myocardial infarction. N Engl J Med. 1989;321:712-716.
47. Vatterott PJ, Hammill SC, Bailey KR, Wiltgen CM, Bailey KR, Gersh BJ. Late potential on signal-average electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. J Am Coll Cardiol. 1991;17:330-337.
48. Sager PT, Perlmutter RA, Rosenfeld LE, McPherson CA, Wackers FJT, Batsford WP. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol. 1988;12:19-24.
49. Kersschot IE, Brugada P, Ramentol M, Zehcnder M, Waldecker B, Stevenson WG, Geibel A, De Zwaan C, Hein J, Wellens J. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. J Am Coll Cardiol. 1986;7:1234-1242.
50. Montalescot G, Faraggi M, Drobinski G, Messian O, Evans J, Grosgogeat Y, Thomas D. Myocardial viability in patients with O wave myocardial infarction and no residual ischemia. Circulation. 1992;86:47-55.
51. Sabia P, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992;327:1825-1831.
52. Lehmann KG, Francis CK, Dodge HT, and the TIMI Study Group. Mitral regurgitation in early myocardial infarction: incidence, clinical detection, and prognostic implications. Ann Intern Med. 1992;117:10-17.
53. Sharpe DN, Murphy J, Smith H, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988:1:255-259.
54. Bonaduce D, Petretta M, Arrichiello P, Conforti G, Montemurro MV, Attisano T, Bianchi V, Morgano G. Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis. J Am Coll Cardiol. 1992;19:858-863.